SOBHANI, NAVID
SOBHANI, NAVID
Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute
Advances in systemic therapy for malignant mesothelioma: Future perspectives
2017-01-01 Sobhani, Navid; Corona, Silvia Paola; Bonazza, Deborah; Ianza, Anna; Pivetta, Tania; Roviello, Giandomenico; Cortale, Maurizio; Guglielmi, Alessandra; Zanconati, Fabrizio; Generali, Daniele
Advances in systemic therapy for metastatic breast cancer: future perspectives
2017-01-01 Corona, S. P.; Sobhani, Navid; Ianza, Anna; Roviello, Giandomenico; Mustacchi, Giorgio; Bortul, Marina; Zanconati, Fabrizio; Generali, Daniele
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report
2023-01-01 Sobhani, Navid; Bouchè, Victoria; Aldegheri, Giovanni; Rocca, Andrea; D’Angelo, Alberto; Giudici, Fabiola; Bottin, Cristina; Donofrio, Carmine Antonio; Pinamonti, Maurizio; Ferrari, Benvenuto; Panni, Stefano; Cominetti, Marika; Aliaga, Jahard; Ungari, Marco; Fioravanti, Antonio; Zanconati, Fabrizio; Generali, Daniele
Avelumab in gastric cancer
2019-01-01 Roviello, G.; D'Angelo, A.; Generali, D.; Pittacolo, M.; Ganzinelli, M.; Iezzi, G.; De Manzini, N.; Sobhani, N.
Bevacizumab in small cell lung cancer
2017-01-01 Roviello, Giandomenico; Sobhani, Navid; Generali, Daniele
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?
2018-01-01 Sobhani, Navid; Generali, Daniele; Zanconati, Fabrizio; Bortul, Marina; Scaggiante, Bruna
Corticosteroid switch after progression on abiraterone acetate plus prednisone
2020-01-01 Roviello, G.; Sobhani, N.; Corona, S.; D'Angelo, A.
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
2021-01-01 Sobhani, Navid; Tardiel-Cyril, Dana Rae; Davtyan, Aram; Generali, Daniele; Roudi, Raheleh; Li, Yong
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer
2018-01-01 Sobhani, Navid; Generali, Daniele; D’Angelo, Alberto; Aieta, Michele; Roviello, Giandomenico
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
2018-01-01 Sobhani, Navid; Ianza, Anna; D'Angelo, Alberto; Roviello, Giandomenico; Giudici, Fabiola; Bortul, Marina; Zanconati, Fabrizio; Bottin, Cristina; Generali, Daniele
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
2018-01-01 Sobhani, Navid; Generali, Daniele; Zanconati, Fabrizio; Bortul, Marina; Scaggiante, Bruna
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma
2017-01-01 Sobhani, Navid; Corona, Silvia P; Zanconati, Fabrizio; Generali, Daniele
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer
2020-01-01 Sirico, M.; Bernocchi, O.; Sobhani, N.; Giudici, F.; Corona, S. P.; Vernieri, C.; Nichetti, F.; Cappelletti, M. R.; Milani, M.; Strina, C.; Cervoni, V.; Barbieri, G.; Ziglioli, N.; Dester, M.; Bianchi, G. V.; Braud, F. D.; Generali, D.
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5)
2017-01-01 Corona, S. P.; Sobhani, N.; Ianza, A.; Roviello, G.; Mustacchi, G.; Bortul, M.; Zanconati, F.; Generali, D.
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study
2020-01-01 Schettini, Francesco; Sobhani, Navid; Ianza, Anna; Triulzi, Tiziana; Molteni, Alfredo; Lazzari, Maria Chiara; Strina, Carla; Milani, Manuela; Corona, Silvia Paola; Sirico, Marianna; Bernocchi, Ottavia; Giudici, Fabiola; Cappelletti, Maria Rosaria; Ciruelos, Eva; Jerusalem, Guy; Loi, Sherine; Fox, Stephen B.; Generali, Daniele
Lenvatinib for the treatment of renal cell carcinoma
2018-01-01 Roviello, G.; Corona, S.; Bozza, G.; Aieta, M.; Generali, D.; Rodriquenz, M. G.; Mileo, A. M.; Imperatori, M.; Ianza, A.; Conca, R.; Sobhani, N.
Mutant p53 as an antigen in cancer immunotherapy
2020-01-01 Sobhani, N.; D'Angelo, A.; Wang, X.; Young, K. H.; Generali, D.; Li, Y.
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma
2017-01-01 Sobhani, Navid; Roviello, Giandomenico; Corona, S. P.; Ianza, Anna; Zanconati, Fabrizio; Generali, Daniele
P53 antibodies as a diagnostic marker for cancer: A meta-analysis
2021-01-01 Sobhani, N.; Roviello, G.; D'Angelo, A.; Roudi, R.; Neeli, P. K.; Generali, D.
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy
2017-01-01 Sobhani, Navid; Generali, Daniele; Roviello, Giandomenico